Revenue and Profitability - Revenue for Q1 2024 reached ¥178,058,819.17, an increase of 14.02% compared to ¥156,157,878.04 in the same period last year[5] - Net profit attributable to shareholders decreased by 18.70% to ¥17,670,252.56 from ¥21,734,165.63 year-on-year[5] - Net profit excluding non-recurring gains and losses fell by 25.51% to ¥16,392,710.49 compared to ¥22,006,652.20 in the previous year[5] - Basic and diluted earnings per share decreased by 38.46% to ¥0.24 from ¥0.39 year-on-year[5] - Total operating revenue for Q1 2024 was CNY 178,058,819.17, an increase of 13.96% compared to CNY 156,157,878.04 in Q1 2023[21] - Net profit for Q1 2024 was CNY 17,638,311.26, a decrease of 18.88% from CNY 21,734,165.63 in Q1 2023[22] - Operating profit for Q1 2024 was CNY 20,955,014.45, down 17.00% from CNY 25,240,248.76 in the previous year[22] - Earnings per share for Q1 2024 was CNY 0.24, compared to CNY 0.39 in Q1 2023[23] Cash Flow and Liquidity - Operating cash flow turned negative at -¥1,495,654.65, a decline of 170.47% from a positive cash flow of ¥2,122,328.64 in the same period last year[5] - Cash inflow from operating activities was CNY 92,707,705.87, an increase from CNY 85,497,919.22 in the same quarter last year[25] - The net cash outflow from operating activities was CNY 1,495,654.65, compared to a net inflow of CNY 2,122,328.64 in the previous period, indicating a significant decline in operational cash flow[26] - The net cash inflow from investment activities was CNY 58,471,234.40, a turnaround from a net outflow of CNY 31,495,850.03 in the previous period, reflecting improved investment performance[26] - Cash and cash equivalents increased by CNY 61,419,505.63, compared to an increase of CNY 13,285,063.24 in the previous period, showing a stronger liquidity position[26] - Total cash inflow from financing activities was CNY 101,116,615.87, up from CNY 50,320,620.18 in the previous period, indicating increased financing efforts[26] - The company paid CNY 85,469,481.30 in debt repayments, significantly higher than CNY 3,297,509.37 in the previous period, reflecting a focus on reducing leverage[26] - The company reported a total cash balance of CNY 410,352,775.67 at the end of the period, compared to CNY 21,911,081.36 at the end of the previous period, indicating a substantial increase in cash reserves[26] Assets and Liabilities - Total assets increased by 0.58% to ¥1,841,801,467.55 from ¥1,831,102,296.46 at the end of the previous year[5] - Total liabilities decreased slightly, with current liabilities totaling ¥482,221,786.11 compared to ¥489,498,084.54, a decrease of about 1.6%[18] - The total liabilities at the end of Q1 2024 were CNY 536,536,449.88, a decrease from CNY 545,474,225.20 at the beginning of the quarter[22] - Short-term borrowings decreased to ¥182,484,606.87 from ¥217,337,131.55, a reduction of approximately 16.0%[18] - Total equity attributable to shareholders of the parent company increased to CNY 1,303,796,958.97 from CNY 1,285,628,071.26 at the beginning of the quarter[22] Operational Performance - Accounts receivable increased by 43.22% due to higher sales revenue during the period[9] - Prepayments surged by 90.03% primarily due to advance payments for procurement[9] - Sales expenses grew by 52.63% driven by increased export sales and related customs fees[10] - The company's production capacity utilization is improving, with certain product demands showing strong recovery, supporting operational performance[15] - The company is focusing on niche products with higher margins and less competition, aligning with industry trends to enhance long-term sustainability[15] - The company's strategy of differentiation and focusing on niche markets has allowed for flexible adjustments in operational strategies[15] - Research and development expenses for Q1 2024 were CNY 4,379,916.17, a decrease of 32.36% from CNY 6,462,811.86 in Q1 2023[22] - Financial expenses for Q1 2024 were CNY 1,394,119.37, down 51.85% from CNY 2,896,890.29 in the previous year[22] Accounting and Reporting - The company has not yet adopted the new accounting standards for the current year, which may impact future financial reporting[27] - The first quarter report was not audited, which may affect the reliability of the financial data presented[27]
广康生化(300804) - 2024 Q1 - 季度财报